A Phase 1, Dose Escalation Study of Guadecitabine (SGI-110) in Combination with Pembrolizumab in Patients with Solid Tumours
View/
Metadata
Show full item recordCollections
Except where otherwise noted, this item's license is described
as
http://creativecommons.org/licenses/by/4.0/